The Sigma Healthcare Ltd (ASX: SIG) share price is in focus as the company reports strong Chemist Warehouse sales growth, with Australian stores up 16.7% and international stores up 24.7% to date this financial year.
What did Sigma Healthcare report?
- Australian Chemist Warehouse sales grew 16.7% year-to-date, with like-for-like growth of 14.4%
- International Chemist Warehouse sales rose 24.7%, like-for-like growth of 11.8%
- Ongoing uplift from GLP1 sales continues in Australia
- Entered a joint venture to launch Chemist Warehouse in the UK
- Committed to a new 23,000 square metre distribution centre in New Zealand
What else do investors need to know?
Sigma has signed a memorandum of understanding with GreenLight Healthcare to bring the Chemist Warehouse brand to the United Kingdom. The initial focus will be on rebranding up to five London area stores, with plans for more if successful.
The company is also investing approximately A$40 million in its New Zealand supply chain. A new distribution centre will support a growing NZ store network, aiming for more than 100 Chemist Warehouse locations long term.
What’s next for Sigma Healthcare?
Sigma expects to launch its first Chemist Warehouse store in the UK by rebranding one of GreenLight’s existing locations in London. Phase one will focus on up to five sites, with potential to expand further if these pilot stores perform well.
The new distribution centre in New Zealand is scheduled to begin operations in September 2026, with warehouse automation rolling out in the second half of 2027. This investment is designed to future-proof Sigma’s supply chain as the New Zealand store network grows.
Sigma Healthcare share price snapshot
Over the past 12 months, Sigma Healthcare shares have declined 10%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 7% over the same period.
The post Sigma Healthcare delivers double digit Chemist Warehouse sales growth in 2026 appeared first on The Motley Fool Australia.
Should you invest $1,000 in Sigma Healthcare right now?
Before you buy Sigma Healthcare shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Sigma Healthcare wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Pinnacle Investment Management increases Metrics Credit stake in $100.5 million deal
- PEXA shares: Strong 3Q26 results and FY26 guidance reaffirmed
- Austal wins extra $136m patrol boat contract, lifts order book above $17.7bn
- Here are the top 10 ASX 200 shares today
- Viva Energy updates investors on Geelong Refinery operations
Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.